BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35269519)

  • 1. PTH-Induced Bone Regeneration and Vascular Modulation Are Both Dependent on Endothelial Signaling.
    Cohn-Schwartz D; Schary Y; Yalon E; Krut Z; Da X; Schwarz EM; Gazit D; Pelled G; Gazit Z
    Cells; 2022 Mar; 11(5):. PubMed ID: 35269519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTH promotes allograft integration in a calvarial bone defect.
    Sheyn D; Cohn Yakubovich D; Kallai I; Su S; Da X; Pelled G; Tawackoli W; Cook-Weins G; Schwarz EM; Gazit D; Gazit Z
    Mol Pharm; 2013 Dec; 10(12):4462-71. PubMed ID: 24131143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid hormone induces bone formation in phosphorylation-deficient PTHR1 knockin mice.
    Datta NS; Samra TA; Abou-Samra AB
    Am J Physiol Endocrinol Metab; 2012 May; 302(10):E1183-8. PubMed ID: 22338074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutively active PTH/PTHrP receptor specifically expressed in osteoblasts enhances bone formation induced by bone marrow ablation.
    Ono N; Nakashima K; Schipani E; Hayata T; Ezura Y; Soma K; Kronenberg HM; Noda M
    J Cell Physiol; 2012 Feb; 227(2):408-15. PubMed ID: 21866553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation in the PTH pathway and bone phenotypes in elderly women: evaluation of PTH, PTHLH, PTHR1 and PTHR2 genes.
    Tenne M; McGuigan F; Jansson L; Gerdhem P; Obrant KJ; Luthman H; Akesson K
    Bone; 2008 Apr; 42(4):719-27. PubMed ID: 18280230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-cadherin restrains PTH activation of Lrp6/β-catenin signaling and osteoanabolic action.
    Revollo L; Kading J; Jeong SY; Li J; Salazar V; Mbalaviele G; Civitelli R
    J Bone Miner Res; 2015 Feb; 30(2):274-85. PubMed ID: 25088803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mice expressing a constitutively active PTH/PTHrP receptor in osteoblasts show reduced callus size but normal callus morphology during fracture healing.
    Marsell R; Jonsson KB; Cho TJ; Einhorn TA; Ohlsson C; Schipani E
    Acta Orthop; 2007 Feb; 78(1):39-45. PubMed ID: 17453391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of parathyroid hormone therapy in reversing radiation-induced nonunion and normalization of radiomorphometrics in a murine mandibular model of distraction osteogenesis.
    Gallagher KK; Deshpande S; Tchanque-Fossuo CN; Donneys A; Sarhaddi D; Nelson NS; Chepeha DB; Buchman SR
    Head Neck; 2013 Dec; 35(12):1732-7. PubMed ID: 23335324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic administration of mesenchymal stem cells combined with parathyroid hormone therapy synergistically regenerates multiple rib fractures.
    Cohn Yakubovich D; Sheyn D; Bez M; Schary Y; Yalon E; Sirhan A; Amira M; Yaya A; De Mel S; Da X; Ben-David S; Tawackoli W; Ley EJ; Gazit D; Gazit Z; Pelled G
    Stem Cell Res Ther; 2017 Mar; 8(1):51. PubMed ID: 28279202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined treatment with vitamin K2 and PTH enhanced bone formation in ovariectomized rats and increased differentiation of osteoblast in vitro.
    Weng SJ; Yan DY; Gu LJ; Chen L; Xie ZJ; Wu ZY; Tang JH; Shen ZJ; Li H; Bai BL; Boodhun V; Yang L
    Chem Biol Interact; 2019 Feb; 300():101-110. PubMed ID: 30639440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Per-1 is a specific clock gene regulated by parathyroid hormone (PTH) signaling in osteoblasts and is functional for the transcriptional events induced by PTH.
    Hanyu R; Hayata T; Nagao M; Saita Y; Hemmi H; Notomi T; Nakamoto T; Schipani E; Knonenbery H; Kaneko K; Kurosawa H; Ezura Y; Noda M
    J Cell Biochem; 2011 Feb; 112(2):433-8. PubMed ID: 21268064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3', 5'-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells.
    Nakao Y; Koike T; Ohta Y; Manaka T; Imai Y; Takaoka K
    Bone; 2009 May; 44(5):872-7. PubMed ID: 19442611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chemokine Cxcl1 is a novel target gene of parathyroid hormone (PTH)/PTH-related protein in committed osteoblasts.
    Onan D; Allan EH; Quinn JM; Gooi JH; Pompolo S; Sims NA; Gillespie MT; Martin TJ
    Endocrinology; 2009 May; 150(5):2244-53. PubMed ID: 19147675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of parathyroid hormone (PTH) receptor 1 in T cells blunts the bone anabolic activity of PTH.
    Bedi B; Li JY; Tawfeek H; Baek KH; Adams J; Vangara SS; Chang MK; Kneissel M; Weitzmann MN; Pacifici R
    Proc Natl Acad Sci U S A; 2012 Mar; 109(12):E725-33. PubMed ID: 22393015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The VDR, COL1A1, PTH, and PTHR1 gene polymorphisms are not associated with bone size and height in Chinese nuclear families.
    Lei SF; Wang YB; Liu MY; Mo XY; Deng HW
    J Bone Miner Metab; 2005; 23(6):501-5. PubMed ID: 16261459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid hormone stimulates bone regeneration in an atrophic non-union model in aged mice.
    Menger MM; Tobias AL; Bauer D; Bleimehl M; Scheuer C; Menger MD; Histing T; Laschke MW
    J Transl Med; 2023 Nov; 21(1):844. PubMed ID: 37996876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal epidermal growth factor receptor signaling is dispensable for bone anabolic effects of parathyroid hormone.
    Schneider MR; Dahlhoff M; Andrukhova O; Grill J; Glösmann M; Schüler C; Weber K; Wolf E; Erben RG
    Bone; 2012 Jan; 50(1):237-44. PubMed ID: 22056328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of endogenous parathyroid hormone delays fracture healing by inhibiting vascular endothelial growth factor‑mediated angiogenesis.
    Ding Q; Sun P; Zhou H; Wan B; Yin J; Huang Y; Li Q; Yin G; Fan J
    Int J Mol Med; 2018 Jul; 42(1):171-181. PubMed ID: 29620150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Climbing exercise enhances osteoblast differentiation and inhibits adipogenic differentiation with high expression of PTH/PTHrP receptor in bone marrow cells.
    Menuki K; Mori T; Sakai A; Sakuma M; Okimoto N; Shimizu Y; Kunugita N; Nakamura T
    Bone; 2008 Sep; 43(3):613-20. PubMed ID: 18567552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous parathyroid hormone-related protein compensates for the absence of parathyroid hormone in promoting bone accrual in vivo in a model of bone marrow ablation.
    Zhu Q; Zhou X; Zhu M; Wang Q; Goltzman D; Karaplis A; Miao D
    J Bone Miner Res; 2013 Sep; 28(9):1898-911. PubMed ID: 23716486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.